AST SpaceMobile is building a space-based cellular broadband network designed to connect directly to standard, unmodified smartphones through a constellation of low Earth orbit (LEO) satellites. Its flagship BlueBird satellites are assembled and tested at the company's facilities in Midland, Texas, with production advancing through the BlueBird 50 unit. Rather than selling service directly to consumers, ASTS uses a wholesale model, partnering with mobile network operators to extend coverage into rural, remote, and underserved areas.
Investors follow ASTS closely because the company sits at the center of the emerging direct-to-device market, competing for a commercial opportunity that could redefine how cellular connectivity reaches areas beyond terrestrial towers. The company's technology has demonstrated peak download speeds near 98.9 Mbps, with next-generation satellites expected to reach roughly 200 Mbps, underscoring both its technical potential and its capital-intensive, pre-revenue stage of development.
Over the last 30 days, ASTS declined approximately 35.3%, falling from a closing level near $61.81 to roughly $40. The decline was concentrated in October, when the stock broke below several technical support levels amid a sharp re-rating of the direct-to-device sector. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The broader quarterly picture reflects a more sustained reversal. After climbing to an intraday high above $74 in mid-August, ASTS surrendered those gains and entered a multi-month downtrend, finishing the trailing three-month period down roughly 30% from late-July levels. The move marks a meaningful unwinding of the premium valuation the stock carried earlier in the year, even as the company's fundamental rollout timeline remained largely intact.
The dominant catalyst was SpaceX's purchase of low-band spectrum for about $8 billion, a move that brings the company closer to offering full mobile wireless services. The announcement rippled across the telecom sector, pressuring shares of wireless carriers and satellite connectivity providers alike, and raised direct questions about AST SpaceMobile's competitive position.
The news triggered a sharp reset in analyst sentiment. Piper Sandler downgraded ASTS to Neutral from Overweight and cut its price target to $54 from $98, citing lower conviction in the pace of satellite launches and concerns that SpaceX could reduce launch capacity for competing services. By contrast, Deutsche Bank upgraded the stock to Buy from Hold, noting the shares had fallen substantially from highs and arguing that terrestrial carriers need AST's wholesale model to compete. Scotiabank later upgraded ASTS to Outperform, calling the valuation "reasonably attractive, if not a bargain," while Berenberg maintained a Buy rating, contending the SpaceX deal makes AST's carrier-aligned approach more strategically relevant.
A securities class action, with a lead plaintiff deadline of November 13, 2026, added a legal overhang, while the company renewed a three-year executive agreement with its CFO and continued advancing its service-readiness milestones. Together, these factors amplified volatility and investor uncertainty during the period.
The quarterly decline reflects a shift in the market's risk appetite for high-multiple, pre-revenue space companies. Earlier in the period, optimism around BlueBird satellite production and initial service timelines supported the stock's run toward its August peak. As competitive pressures from SpaceX's direct-to-cell ambitions became more concrete, investors began repricing the probability and pace of ASTS's revenue ramp.
Meanwhile, persistently negative earnings and elevated valuation multiples left the shares vulnerable to sentiment shifts. The company has continued to report operating losses as it builds out its constellation, and a backdrop of high short interest added further turbulence. The result was a broad de-rating that outweighed the company's steady operational progress on gateways, spectrum access, and coverage-cell activation.
Looking ahead, investors are likely to focus on the company's progress toward initial, intermittent coverage in the United States, Canada, Japan, the United Kingdom, and Saudi Arabia, subject to regulatory approvals. The pace of BlueBird satellite production and launches, spectrum access milestones, and the activation of coverage cells will be closely watched indicators of execution.
Competitive developments remain central, particularly SpaceX's spectrum strategy and the rollout of its next-generation Starlink satellites, which could narrow ASTS's technology lead. Regulatory decisions, the outcome of the pending securities litigation, and any changes in analyst ratings or price targets are additional factors that could influence sentiment. Macroeconomic conditions and broader risk appetite for unprofitable growth companies will also play a role, given the stock's sensitivity to valuation shifts.
One resource I turn to when evaluating names like this is Tickeron’s AI Trading Bots. The platform hosts hundreds of bots trading thousands of tickers, and its Trending AI Robots section highlights only the top-performing and most relevant strategies. These range from short-term momentum approaches to longer-horizon models, giving investors a practical way to align automated signals with their own objectives and complement fundamental research on ASTS.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ASTS saw its Momentum Indicator move below the 0 level on November 02, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned negative. In 74 of the 81 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for ASTS turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 48 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for ASTS entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +22.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASTS advanced for three days, in 231 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
ASTS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.117) is normal, around the industry mean (5.210). P/E Ratio (-15.037) is within average values for comparable stocks, (3.688). ASTS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.778). Dividend Yield (0.000) settles around the average of (0.067) among similar stocks. ASTS's P/S Ratio (147.059) is very high in comparison to the industry average of (11.937).
The Tickeron Profit vs. Risk Rating rating for this company is 89 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. ASTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a blank check company, which has formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization
Industry TelecommunicationsEquipment